Charlie Weller | Head of Vaccines
Wellcome Trust

Charlie Weller is Head of Vaccines in the Infectious Diseases Area at Wellcome. Since 2016, she led a team to develop new and improved vaccines & antibodies, gaining a better understanding of protective immunity and strengthening the connection between research and decision makers. Charlie joined Wellcome in 2014 and led the funding response to the Ebola epidemic of 2014-2015 and managed the epidemics research activities. Charlie was involved in founding CEPI and currently chairs CEPI Investors Council and contributes to a number of national and international advisory committees in vaccines and epidemics. Before joining Wellcome Charlie gained over 16 years of research experience in both academic and pharmaceutical environments, ranging from host pathogen interactions to cellular and molecular immunology. Including leading target identification and validation in the respiratory disease area at Novartis. Prior to this, Charlie investigated cell localization and function in health, respiratory disease and parasite infections as a postdoctoral fellow at Imperial College London.